Applied DNA Sciences (“Applied DNA”) is a biotechnology company with over 20 years of experience in developing and commercializing polymerase chain reaction (PCR)-based applications for DNA production. Through our majority-owned subsidiary, LineaRx Inc., we are commercializing a differentiated, synthetic DNA approach to the manufacture of the next generation of nucleic acid-based therapie.
The corporate headquarters of Applied DNA is located at:
50 Health Sciences Drive
Stony Brook, NY 11790
Tel +1-631-240-8800
Fax +1-631-240-8900
Applied DNA is incorporated in the state of Delaware.
Applied DNA operates on a September 30 fiscal year.
Applied DNA common stock is listed on the Nasdaq Capital Market under the ticker symbol ‘APDN’.
Shares outstanding as of July 7, 2025, stood at 958,465.
CBIZ CPAs P.C.
68 South Service Road
Suite 300
Melville, N.Y. 11747
(631) 414-4000
Equiniti Trust Company
Tel: (800) 937-5449 OR (718) 921-8124
URL: https://equiniti.com/us/ast-access/individuals/
The transfer agent is responsible for maintaining all records of stockholders (including change of address, telephone number, and name), canceling or issuing stock certificates, and resolving problems related to lost, destroyed, or stolen certificates.
No, Applied DNA does not offer a direct stock purchase plan.
No, Applied DNA does not pay a dividend at this time.
SEC filings are available at the following address: SEC Filings
Please contact
Sanjay M. Hurry
Executive Director, Investor Relations and Corporate Communications
E: sanjay.hurry@adnas.com
M: 917-733-5573